DE60141827D1 - Verwendung des globulären kopfes von acrp30 zur verstärkung der zunahme von muskelmasse und -differenzierung - Google Patents
Verwendung des globulären kopfes von acrp30 zur verstärkung der zunahme von muskelmasse und -differenzierungInfo
- Publication number
- DE60141827D1 DE60141827D1 DE60141827T DE60141827T DE60141827D1 DE 60141827 D1 DE60141827 D1 DE 60141827D1 DE 60141827 T DE60141827 T DE 60141827T DE 60141827 T DE60141827 T DE 60141827T DE 60141827 D1 DE60141827 D1 DE 60141827D1
- Authority
- DE
- Germany
- Prior art keywords
- muscle
- increase
- muscle mass
- acrp30
- differentiation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 210000003205 muscle Anatomy 0.000 title abstract 7
- 102000011690 Adiponectin Human genes 0.000 title 1
- 108010076365 Adiponectin Proteins 0.000 title 1
- 230000004069 differentiation Effects 0.000 title 1
- 206010028289 Muscle atrophy Diseases 0.000 abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 201000000585 muscular atrophy Diseases 0.000 abstract 2
- 230000003190 augmentative effect Effects 0.000 abstract 1
- 230000024245 cell differentiation Effects 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037765 diseases and disorders Diseases 0.000 abstract 1
- 208000035475 disorder Diseases 0.000 abstract 1
- 235000021588 free fatty acids Nutrition 0.000 abstract 1
- 230000020763 muscle atrophy Effects 0.000 abstract 1
- 210000000663 muscle cell Anatomy 0.000 abstract 1
- 201000006938 muscular dystrophy Diseases 0.000 abstract 1
- 230000003647 oxidation Effects 0.000 abstract 1
- 238000007254 oxidation reaction Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/2264—Obesity-gene products, e.g. leptin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Toxicology (AREA)
- Immunology (AREA)
- Endocrinology (AREA)
- Obesity (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Neurology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US20825100P | 2000-05-31 | 2000-05-31 | |
US23973500P | 2000-10-11 | 2000-10-11 | |
PCT/IB2001/001126 WO2001092330A2 (en) | 2000-05-31 | 2001-05-22 | Use of acrp30 globular head to promote increases in muscle mass and muscle differentiation |
Publications (1)
Publication Number | Publication Date |
---|---|
DE60141827D1 true DE60141827D1 (de) | 2010-05-27 |
Family
ID=26903041
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE60141827T Expired - Lifetime DE60141827D1 (de) | 2000-05-31 | 2001-05-22 | Verwendung des globulären kopfes von acrp30 zur verstärkung der zunahme von muskelmasse und -differenzierung |
Country Status (9)
Country | Link |
---|---|
US (2) | US7405193B2 (de) |
EP (1) | EP1294866B1 (de) |
JP (1) | JP2003535104A (de) |
AT (1) | ATE464378T1 (de) |
AU (2) | AU781253B2 (de) |
CA (1) | CA2410758A1 (de) |
DE (1) | DE60141827D1 (de) |
IL (2) | IL153200A0 (de) |
WO (1) | WO2001092330A2 (de) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050288223A1 (en) * | 2002-05-17 | 2005-12-29 | Genset S.A. | OBG3 Fragments Inhibiting The Conversion Of Active OBG3 Into Less Active OBG3 And Other Compositions For Treatment Of Metabolic Disorders |
CA2524255C (en) | 2003-03-21 | 2014-02-11 | Academisch Ziekenhuis Leiden | Modulation of exon recognition in pre-mrna by interfering with the secondary rna structure |
WO2005113599A1 (en) * | 2004-05-21 | 2005-12-01 | Xencor, Inc. | C1q family member proteins with altered immunogenicity |
NZ574807A (en) * | 2006-08-11 | 2011-01-28 | Prosensa Technologies Bv | Methods and means for treating dna repeat instability associated genetic disorders |
WO2009008727A2 (en) * | 2007-07-12 | 2009-01-15 | Prosensa Technologies B.V. | Molecules for targeting compounds to various selected organs or tissues |
CN101790385A (zh) * | 2007-07-12 | 2010-07-28 | 普罗森那技术公司 | 用于使化合物靶向多种选定器官、组织或肿瘤细胞的分子 |
CN105641700B (zh) | 2007-10-26 | 2021-01-01 | 莱顿教学医院 | 对抗肌肉病症的方式和方法 |
USRE48468E1 (en) | 2007-10-26 | 2021-03-16 | Biomarin Technologies B.V. | Means and methods for counteracting muscle disorders |
EP2088156A1 (de) | 2008-02-08 | 2009-08-12 | Institut Pasteur | Verwendung von Adiponektin zur Diagnose und/oder Behandlung von Presbyakusis |
EP2119783A1 (de) | 2008-05-14 | 2009-11-18 | Prosensa Technologies B.V. | Verfahren für effizientes Exon (44)-Skipping bei Duchenne-Muskeldystrophie und entsprechende Mittel |
JP2012524540A (ja) | 2009-04-24 | 2012-10-18 | プロセンサ テクノロジーズ ビー.ブイ. | Dmdを処置するためのイノシンを含むオリゴヌクレオチド |
WO2011078672A1 (en) | 2009-12-24 | 2011-06-30 | Prosensa Technologies B.V. | Molecule for treating an inflammatory disorder |
CN112251436A (zh) | 2012-01-27 | 2021-01-22 | 比奥马林技术公司 | 治疗杜兴型肌营养不良症和贝克型肌营养不良症的具有改善特性的rna调节性寡核苷酸 |
KR101438744B1 (ko) * | 2012-08-02 | 2014-09-15 | 전남대학교산학협력단 | 아디포넥틴을 유효성분으로 포함하는 안구건조증 또는 염증성 안구표면 질환의 예방 또는 치료용 조성물 |
JP6539511B2 (ja) * | 2015-06-17 | 2019-07-03 | 花王株式会社 | 運動機能の判定用マーカー |
NL2015032B1 (en) | 2015-06-26 | 2017-01-24 | Vitalnext B V | Compositions and methods for the treatment of malnutrition. |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5869330A (en) | 1995-06-05 | 1999-02-09 | Whitehead Institute For Biomedical Research | DNA encoding a novel serum protein produced exclusively in adipocytes |
FR2767135B1 (fr) | 1997-08-06 | 2002-07-12 | Genset Sa | Recepteur complexe lsr, activite, clonage, et application au diagnostic, a la prevention et/ou au traitement de d'obesite et des risques ou complications associes |
EP1033134B8 (de) * | 1997-10-29 | 2007-09-19 | Otsuka Pharmaceutical Co., Ltd. | Compositions zur inhibierung der proliferation glatter muskulatur und verfahren zur diagnose von arteriosklerose |
AU785090B2 (en) | 2000-01-14 | 2006-09-14 | Serono Genetics Institute S.A. | OBG3 globular head and uses thereof for decreasing body mass |
US6579852B2 (en) | 2000-01-14 | 2003-06-17 | Genset S.A. | OBG3 globular head and uses thereof for decreasing body mass |
US6989367B2 (en) | 2000-01-14 | 2006-01-24 | Genset S.A. | OBG3 globular head and uses thereof |
US6566332B2 (en) | 2000-01-14 | 2003-05-20 | Genset S.A. | OBG3 globular head and uses thereof for decreasing body mass |
US20020058617A1 (en) | 2000-01-14 | 2002-05-16 | Joachim Fruebis | OBG3 globular head and uses thereof for decreasing body mass |
US7338787B2 (en) | 2000-01-14 | 2008-03-04 | Serono Genetics Institute S.A. | Nucleic acids encoding OBG3 globular head and uses thereof |
AU2002251433A1 (en) | 2001-02-02 | 2002-08-12 | Genset | Gssp3 polynucleotides and polypeptides and uses thereof |
US6867189B2 (en) | 2001-07-26 | 2005-03-15 | Genset S.A. | Use of adipsin/complement factor D in the treatment of metabolic related disorders |
JP2005514010A (ja) | 2001-10-12 | 2005-05-19 | セローノ ジェネティクス インスティテュート ソシエテ アノニム | Ngzipa、ngzipd、pgzipaおよびpgzipdポリヌクレオチドおよびポリペプチド、ならびにその使用 |
-
2001
- 2001-05-22 AT AT01940910T patent/ATE464378T1/de not_active IP Right Cessation
- 2001-05-22 WO PCT/IB2001/001126 patent/WO2001092330A2/en active IP Right Grant
- 2001-05-22 DE DE60141827T patent/DE60141827D1/de not_active Expired - Lifetime
- 2001-05-22 IL IL15320001A patent/IL153200A0/xx unknown
- 2001-05-22 US US10/296,865 patent/US7405193B2/en not_active Expired - Fee Related
- 2001-05-22 EP EP01940910A patent/EP1294866B1/de not_active Expired - Lifetime
- 2001-05-22 CA CA002410758A patent/CA2410758A1/en not_active Abandoned
- 2001-05-22 JP JP2002500941A patent/JP2003535104A/ja active Pending
- 2001-05-22 AU AU74398/01A patent/AU781253B2/en not_active Ceased
-
2002
- 2002-12-01 IL IL153200A patent/IL153200A/en not_active IP Right Cessation
-
2005
- 2005-07-29 AU AU2005203365A patent/AU2005203365B2/en not_active Ceased
-
2008
- 2008-06-27 US US12/147,612 patent/US20080274971A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO2001092330A3 (en) | 2002-08-22 |
US20060035824A1 (en) | 2006-02-16 |
CA2410758A1 (en) | 2001-12-06 |
ATE464378T1 (de) | 2010-04-15 |
AU2005203365B2 (en) | 2008-02-14 |
AU7439801A (en) | 2001-12-11 |
EP1294866A2 (de) | 2003-03-26 |
EP1294866B1 (de) | 2010-04-14 |
WO2001092330A2 (en) | 2001-12-06 |
AU2005203365A1 (en) | 2005-08-25 |
IL153200A (en) | 2010-05-17 |
AU781253B2 (en) | 2005-05-12 |
US7405193B2 (en) | 2008-07-29 |
JP2003535104A (ja) | 2003-11-25 |
US20080274971A1 (en) | 2008-11-06 |
IL153200A0 (en) | 2003-07-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE60141827D1 (de) | Verwendung des globulären kopfes von acrp30 zur verstärkung der zunahme von muskelmasse und -differenzierung | |
ATE305296T1 (de) | Zusammensetzungen und verfahren zur behandlung von abnormaler zellvermehrung | |
DE69909775D1 (de) | Neue fettanaloge zur behandlung von diabetes | |
ATE395052T1 (de) | Verwendung von c-kit-inhibitoren für die behandlung von typ-2-diabetes | |
ATE309358T1 (de) | Superaktive, wachstumshormone freisetzende hormonanaloge vom schwein | |
ATE356113T1 (de) | Probucolbernsteinsäureester zur hemmung der expression von vcam-1 | |
ATE342964T1 (de) | Rekombinante alpha-l-iduronisase, deren herstellungs- und aufreinigungsverfahren, und behandlung von durch diese hervorgerufene mangelerkrankungen | |
GEP20053660B (en) | Novel Tyrosine Kinase Inhibitors | |
TW200519202A (en) | Modulation of eIF4E expression | |
TW200502385A (en) | Modulation of forkhead box o1a expression | |
DE60011100D1 (de) | Als cox-hemmer verwendbare sulfonylphenylpyrazol-verbindungen | |
EA200201214A1 (ru) | Замещенные тиоацетамиды | |
ATE340515T1 (de) | Fraktionierung und behandlung von ölsaatmehl | |
HK1059439A1 (en) | Compounds having activity as inhibitors of cytochrome p450rai | |
ATE330608T1 (de) | Die verwendung von n-phenyl-2-pyrimidine-amine derivaten zur behandlung von entzündlichen erkrankungen | |
DE60130661D1 (de) | Verwendung der 13-cis retinsäure zur behandlung von emphysemen | |
DE60307237D1 (de) | Verwendung von tyrosine-kinase inhibitoren zur behandlung von cns krankheiten | |
DE60216281D1 (de) | Die verwendung von tyrosinkinasehemmer zur behandlung von allergischen erkrankungen | |
WO2000030667A3 (en) | Compositions and methods using lactadherin or variants thereof | |
ATE322244T1 (de) | Verwendung von polyaminosäurederivaten zur behandlung von seborrhoe und verwandten hautstörungen | |
DE60224064D1 (de) | Fragmente des humanen zn-alpha2-glykoproteins und deren verwendung in methoden zur behandlung der fettleibigkeit | |
ATE345121T1 (de) | Verwendung von konjugierter linolsäure zur behandlung der erkältung | |
DE502004012196D1 (de) | Verwendung von isorhamnetin zur behandlung von depressiven verstimmungen und erkrankungen | |
ATE409469T1 (de) | Verwendung von 2,2,3,3, tetramethylcyclopropane carbonsäure derivaten zur behandlung von psychiatrischen störungen | |
WO2003105754A3 (en) | ANTISENSE MODULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR B (VEGF-B) EXPRESSION |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |